AI assistant
Roivant Sciences Ltd. — Director's Dealing 2025
Jun 23, 2025
30587_dirs_2025-06-23_d1762476-770d-4850-8bbe-6d4b8c42481c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2025-06-18
Reporting Person: Ramaswamy Vivek (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-18 | Common Shares | S | 565266 | $11.45 | Disposed | 37861115 | Direct |
| 2025-06-20 | Common Shares | S | 577007 | $11.46 | Disposed | 37284108 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares | 13357857 | Indirect |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.41 to $11.53, inclusive. The reporting person undertakes to provide to Roivant Sciences Ltd., any security holder of Roivant Sciences Ltd., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.45 to $11.54, inclusive.
F3: Represents the quantity of shares held indirectly only.